https://www.selleckchem.com/pr....oducts/epacadostat-i
Moreover, molecular deletion of Galectin-3-β-catenin signalling synergistically improved the antitumour effect of sorafenib. The Galectin-3-β-catenin-IGFBP3/vimentin signalling cascade was determined as a central mechanism controlling HCC metastasis, providing possible biomarkers for predicating vascular metastasis and sorafenib resistance, as well as potential therapeutic targets for the treatment of HCC patients. The Galectin-3-β-catenin-IGFBP3/vimentin signalling cascade was determined as a central mechanism controllin
Like
Comment
Share
